The impact of vaccination on rhinosinusitis and otitis media

Michael S Benninger1, Ryan Manz

  • 1Head and Neck Institute, The Cleveland Clinic, OH 44139, USA. benninm@ccf.org

Insights

Childhood vaccines significantly impact acute otitis media (AOM) and acute bacterial rhinosinusitis (ABRS). While reducing some pathogens, vaccination has led to shifts in bacterial causes, including increased Staphylococcus aureus.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Microbiology

Background:

  • Acute otitis media (AOM) and acute bacterial rhinosinusitis (ABRS) are common childhood infections.
  • The bacteriology and epidemiology of these infections have been influenced by routine childhood vaccinations.

Purpose of the Study:

  • To analyze the impact of routine childhood vaccinations on the frequency and causative agents of AOM and ABRS.
  • To understand the evolving role of specific bacteria, including Streptococcus pneumoniae and Staphylococcus aureus, in these infections post-vaccination.

Main Methods:

  • Review of epidemiological data and microbiological studies on AOM and ABRS.
  • Analysis of the effects of Haemophilus influenzae type b (Hib) and conjugated pneumococcal vaccines.
  • Examination of trends in antibiotic resistance and the emergence of non-vaccine serotypes.

Main Results:

  • Influenza vaccination shows a moderate reduction in AOM.
  • Conjugated pneumococcal vaccines drastically reduced invasive pneumococcal disease and moderately decreased AOM and ABRS.
  • Vaccine serotypes of Streptococcus pneumoniae are largely eliminated, with emergence of other serotypes.
  • Antibiotic resistance in pneumococcal disease has decreased.
  • A decline in S. pneumoniae prevalence may correlate with increased Staphylococcus aureus incidence in AOM/ABRS.

Conclusions:

  • Childhood vaccinations have altered the landscape of AOM and ABRS pathogens.
  • While effective against targeted bacteria, vaccines have led to shifts in microbial ecology, necessitating ongoing surveillance.
  • The rise of Staphylococcus aureus in some cases highlights the complex interplay of bacterial interference and vaccination programs.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...